multi-targeted HIV-1 vaccine (Valens Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemulti-targeted HIV-1 vaccine (Valens Therapeutics)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionHIV envelope protein gp120 inhibitorsHIV integrase inhibitorsHuman Immunodeficiency Virus tat Gene Products inhibitors +[5] 
TargetsHuman Immunodeficiency Virus tat Gene ProductsTransmembrane glycoprotein gp41HIV protease +[5] 
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValens Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValens Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A